SEC Form 4 · accession 0001140361-17-035593
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Demane
Director
Period of report
Sep 13, 2017
Accepted (ET)
Sep 14, 2017 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 13, 2017 | S | 5,000 | $89.50 | D | 42,554 | I | See footnote |
| Common StockF3 | holding | — | — | — | 50,000 | I | See footnote | |
| Common StockF4 | holding | — | — | — | 437,313 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- F3Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retailed Annuity Trust U/A/D May 22, 2017.
- F4Includes 1,518 restricted stock units.